Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MISP | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Misp (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MISP mRNA | CTD | PMID:36331819 | MISP | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Misp (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MISP mRNA | CTD | PMID:22206623 | MISP | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of MISP mRNA | CTD | PMID:30165855 | MISP | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MISP mRNA | CTD | PMID:20106945 and PMID:21632981 | MISP | Human | 4,4'-sulfonyldiphenol | increases methylation | ISO | Misp (Mus musculus) | 6480464 | bisphenol S results in increased methylation of MISP exon | CTD | PMID:33297965 | MISP | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Misp (Mus musculus) | 6480464 | bisphenol S affects the methylation of MISP promoter | CTD | PMID:33297965 | MISP | Human | acetamide | increases expression | ISO | Misp (Rattus norvegicus) | 6480464 | acetamide results in increased expression of MISP mRNA | CTD | PMID:31881176 | MISP | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of MISP mRNA | CTD | PMID:33212167 | MISP | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of MISP gene | CTD | PMID:25304211 | MISP | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of MISP gene | CTD | PMID:25304211 | MISP | Human | arsenite(3-) | decreases methylation | EXP | | 6480464 | arsenite results in decreased methylation of MISP promoter | CTD | PMID:23974009 | MISP | Human | arsenous acid | decreases response to substance | EXP | | 6480464 | MISP protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | MISP | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MISP protein | CTD | PMID:32717239 | MISP | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of MISP promoter | CTD | PMID:30157460 | MISP | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of MISP promoter | CTD | PMID:27901495 | MISP | Human | bisphenol A | affects expression | ISO | Misp (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of MISP mRNA | CTD | PMID:25181051 | MISP | Human | bisphenol A | increases expression | ISO | Misp (Mus musculus) | 6480464 | bisphenol A results in increased expression of MISP mRNA | CTD | PMID:32156529 and PMID:34585602 | MISP | Human | bisphenol A | decreases expression | ISO | Misp (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of MISP mRNA | CTD | PMID:30816183 and PMID:32528016 | MISP | Human | caffeine | affects phosphorylation | EXP | | 6480464 | Caffeine affects the phosphorylation of MISP protein | CTD | PMID:35688186 | MISP | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of MISP mRNA | CTD | PMID:27392435 | MISP | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of MISP mRNA | CTD | PMID:19549813 | MISP | Human | coumarin | increases phosphorylation | EXP | | 6480464 | coumarin results in increased phosphorylation of MISP protein | CTD | PMID:35688186 | MISP | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of MISP mRNA | CTD | PMID:25562108 | MISP | Human | diarsenic trioxide | decreases response to substance | EXP | | 6480464 | MISP protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | MISP | Human | elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of MISP mRNA | CTD | PMID:19244175 | MISP | Human | folic acid | multiple interactions | ISO | Misp (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MISP mRNA | CTD | PMID:22206623 | MISP | Human | gentamycin | decreases expression | ISO | Misp (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of MISP mRNA | CTD | PMID:33387578 | MISP | Human | hexadecanoic acid | decreases phosphorylation | EXP | | 6480464 | Palmitic Acid results in decreased phosphorylation of MISP protein | CTD | PMID:28073184 | MISP | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of MISP protein | CTD | PMID:32959892 | MISP | Human | Monobutylphthalate | decreases expression | ISO | Misp (Mus musculus) | 6480464 | monobutyl phthalate results in decreased expression of MISP mRNA | CTD | PMID:35278568 | MISP | Human | perfluorohexanesulfonic acid | increases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in increased expression of MISP mRNA | CTD | PMID:25812627 | MISP | Human | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of MISP mRNA | CTD | PMID:25812627 | MISP | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Misp (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MISP mRNA | CTD | PMID:36331819 | MISP | Human | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of MISP mRNA and perfluorooctanoic acid results in increased expression of MISP protein | CTD | PMID:25812627 and PMID:26879310 | MISP | Human | quercetin | decreases phosphorylation | EXP | | 6480464 | Quercetin results in decreased phosphorylation of MISP protein | CTD | PMID:35688186 | MISP | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of MISP mRNA | CTD | PMID:23557933 | MISP | Human | selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of MISP mRNA | CTD | PMID:19244175 | MISP | Human | sodium arsenite | decreases expression | ISO | Misp (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of MISP mRNA | CTD | PMID:37682722 | MISP | Human | tributylstannane | increases expression | ISO | Misp (Mus musculus) | 6480464 | tributyltin results in increased expression of MISP mRNA | CTD | PMID:31939706 | MISP | Human | tris(2-butoxyethyl) phosphate | affects expression | EXP | | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of MISP mRNA | CTD | PMID:29024780 | MISP | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of MISP mRNA | CTD | PMID:28818685 | MISP | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of MISP gene | CTD | PMID:29154799 | |